Oxidative stress status in kidney tissue after losartan and atenolol treatment in experimental renal failure

Nephron - Experimental Nephrology

Volumn 97, Issue 2, 2004, Pages

  Pechter, Ülle ^a   Aunapuu, Marina ^a   Riispere, Zivile ^a   Vihalemm, Tiiu ^a   Kullissaar, Tiiu ^a   Zilmer, Kersti ^a   Zilmer, Mihkel ^a   Ots, Mai ^a  

^a UNIVERSITY OF TARTU   (Estonia)

Author keywords

Angiotensin ii receptor antagonist; Chronic renal failure; Losartan; Oxidative stress; Proteinuria

Indexed keywords

ALKENE DERIVATIVE; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CREATININE; GLUTATHIONE; LOSARTAN; MALONALDEHYDE; ISOPROSTANE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD; BLOOD PRESSURE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG EFFECT; KIDNEY CORTEX; KIDNEY FAILURE; KIDNEY PARENCHYMA; LIPID PEROXIDATION; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEINURIA; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; CHRONIC KIDNEY FAILURE; LIPID BLOOD LEVEL; URINARY EXCRETION;

ANIMALS; ATENOLOL; DISEASE MODELS, ANIMAL; KIDNEY; KIDNEY CORTEX; KIDNEY FAILURE, CHRONIC; LOSARTAN; NEPHRECTOMY; OXIDATIVE STRESS; RATS;

EID: 2942701939     PISSN: 16602129     EISSN: None     Source Type: Journal    
DOI: 10.1159/000078404     Document Type: Article

References (17)

1. Nath KA, Croatt AJ, Hostetter TH: Oxygen consumption and oxidant stress in surviving nephrons. Am J Physiol 1990;258:F1354-F1362.
2. Hasdan G, Benchetrit S, Rashid G, Green J, Bernheim J, Rathaus M: Endothelial dysfunction and hypertension in 5/6 nephrectomized rats are mediated by vascular superoxide. Kidney Int 2002;61:586-590.
3. Himmelfarb J, Stenvinkel P, Ikizler TA, Hakim RM: The elephant in uremia: Oxidant stress as a unifying concept of cardiovascular disease in uremia. Kidney Int 2002;62:1524-1538.
4. Ruiz-Ortega M, Lorenzo O, Ruperez M, Esteban V, Suzuki Y, Mezzano S, Plaza JJ, Egido J: Role of the renin-angiotensin system in vascular diseases: Expanding the field. Hypertension 2001;38:1382-1387.
5. Romero JC, Reckelhoff JF: State-of-the-Art lecture. Role of angiotensin and oxidative stress in essential hypertension. Hypertension 1999;34:943-949.
6. Nemeth I, Orvos H, Boda D: Blood glutathione redox status in gestational hypertension. Free Radic Biol Med 2001;30:715-721.
7. Turi S, Friedman A, Bereczki C, Papp F, Kovacs J, Karg E, Nemeth I: Oxidative stress in juvenile essential hypertension. J Hypertens 2003;21:145-152.
8. Wang D, Chen Y, Chabrashvili T, Aslam S, Borrego Conde LJ, Umans JG, Wilcox CS: Role of oxidative stress in endothelial dysfunction and enhanced responses to angiotensin II of afferent arterioles from rabbits infused with angiotensin II. J Am Soc Nephrol 2003;14:2783-2789.
9. Ots M, Mackenzie HS, Troy JL, Rennke HG, Brenner BM: Effects of combination therapy with enalapril and losartan on the rate of progression of renal injury in rats with 5/6 renal mass ablation. J Am Soc Nephrol 1998;9:224-230.
10. Halliwell B, Gutteridge JMC: Free Radicals in Biology and Medicine, ed 3. Oxford, Oxford University Press, 1999, pp 140-163, 393-430.
11. Griffith OW: Determination of glutathione and glutathione disulfide using glutathione reductase and 2-vinylpyridine. Anal Biochem 1980;106:207-212.
12. Hostetter TH, Olson JL, Rennke HG, Venkatachalam MA, Brenner BM: Hyperfiltration in remnant nephrons: A potentially adverse response to renal ablation. Am J Physiol 1981;241:F85-F93.
13. Ritz E, Haxsen V: Angiotensin II and oxidative stress: an unholy alliance. J Am Soc Nephrol 2003;14:2985-2987.
14. Agarwal R: Proinflammatory effects of oxidative stress in chronic kidney disease: Role of additional angiotensin II blockade. Am J Physiol Renal Physiol 2003;284:F863-F869.
15. Donmez G, Derici U, Erbas D, Arinsoy T, Onk A, Sindel S, Hasanoglu E: The effects of losartan and enalapril therapies on the levels of nitric oxide, malondialdehyde, and glutathione in patients with essential hypertension. Jpn J Physiol 2002;52:435-440.
16. Welch WJ, Wilcox CS: AT1 receptor antagonist combats oxidative stress and restores nitric oxide signaling in the SHR. Kidney Int 2001;59:1257-1263.
17. Welch WJ, Baumgartl H, Lubbers D, Wilcox CS: Renal oxygenation defects in the spontaneously hypertensive rat: Role of AT1 receptors. Kidney Int 2003;63:202-208.